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Abstract 
Immunoassays and enzyme-linked immunosorbent assays (ELISA) are one of the key technologies for the 
quantification of a wide range of analytes for serum, plasma and cell lysates.   The protocols of the 
immunoassays have not changed significantly for over 6 decades, as used extensively in both research 
and clinical applications.  However, there is a large demand for the development of new protocols or 
platforms for immunoassays with rapid turnaround time (TAT), high sensitivity and low cost for high 
throughput drug screening, point-of-care clinical diagnostics, or rapid food safety monitoring. Recently, 
microfluidics and lab-on-a-chips (LOC) have been emerging as one of the most promising platforms for 
better immunoassays due to its distinctive natures enabling to meet the demands.  In this talk, the 
distinctive natures of microfluidics and lab-on-a-chips are discussed as a new game changer for 
immunoassays and in vitro diagnostics (IVD), and then its applications to ELISA, IVD and point-of-care 
testing (POCT) clinical diagnostics are introduced 
© 2011 Published by Elsevier Ltd. 
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Enzyme-linked immunosorbent assays (ELISA) are one of the key technologies for the quantification of 
a wide range of analytes for serum, plasma and cell lysates. The basic protocols for ELISA have been 
largely unchanged for a long time, barring innovations in ELISA read out chemistries.  The specificity 
and sensitivity of ELISA are achieved through the use of capture and detect antibodies which have a 
specific affinity to the analytes by its distinct epitopes.   
Lab-on-a-chips (LOC) with microfluidics have been emerging as one of the most promising platforms 
for immunoassays or ELISA, aiming clinical diagnostics, biochemical hazardous agent detection, or food 
inspection.   In specific, the combination of lab-on-a-chips and microfluidics is attractive for the point-of-
care testing (POCT) diagnostics with a desire for rapid response, high sensitivity and low assay cost.  
Microfluidic systems are inherently suited for small sample volumes and allow for rapid reactions owing 
to the limited diffusion lengths.   Microfluidic LOC based POCT devices exploit these features to allow 
for rapid TAT with minimal sample volumes.  In this presentation, the distinctive natures of microfluidics 
and lab-on-a-chips are discussed and then its applications to immunoassays, clinical diagnostics, IVD or 
POCT are presented.   
(a)                                                (b)                                                     (c) 
Figure 1. Microfluidic components and systems developed at University of Cincinnati: (a) Magnetic 
separator and detector system on fluidic mother board [1]; (b) On-chip Tesla micromixer [2]; and (c) 
Blood separator [3]. 
Previous Work 
 The demand for the development of innovative polymer microfluidic platforms for better 
immunoassay, Enzyme-linked immunosorbent assays (ELISA), or in vitro diagnostics (IVD) has been 
continuously growing.  In order to meet the demand, as shown in Figure 1, Microfluidic and BioMEMS 
research team from the University of Cincinnati and Siloam Biosciences has explored and developed 
numerous microfluidic modules and platforms with polymer microfabrication methods using injection 
molding technology [1-4], which includes microvalves and pumps [5], micromixers [2, 6], micro reactors
and incubators [7], separation columns [8], and microfluidic modules [9].   The developed microfluidic 
components and microfabrication technologies have been applied for the development of magnetic bead-
based sampling and electrochemical detection [10], magnetic bead-based immunoassay lab-on-a-chip on 
polymer substrate [11], polymer smart lab-on-a-chip for blood analysis [12, 13], blood sampler and 
immunoassays for IVD [14], and microchannel-based 96-well microplate [15] to showcase the versatility 
of this technology platform to realize “better immunoassays through microfluidics.” 
Magnetic Bead-Based Polymer Lab-on-a-Chip for Immunoassays [11] 
A polymer lab-on-a-chip for magnetic bead-based immunoassay has been developed with capabilities 
of both sampling and detection for point-of-care testing toward biochemical warfare agent detection, food 
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inspection or clinical diagnostics [11]. The fully integrated magnetic lab-on-a-chip on a polymer substrate 
consists of a magnetic bead separator, interdigitated array micro electrodes (IDA), and a micro fluidic 
system, which are fully integrated as an integrated polymer lab-on-a-chip.   
Since the polymer lab-on-a-chip was realized using polymer injection molding techniques, a 
disposable polymer lab-on-a-chip for a magnetic bead-based immunoassay can be successfully realized in 
low cost. The structure design and fabricate device are shown in Figure 2(a) and (b).  ELISA with this 
magnetic lab-on-a-chip using magnetic nano/micro beads was successfully performed using a 
chronoamperometry measurement.  The final results of the magnetic bead based immunoassay are shown 
in Figure 2(c) for measuring Prostate Specific Antigen (PSA) as a potential test for prostrate cancer.   
(a)                                                                    (b)                                                           
Figure 2.  Polymer lab-on-a-chip for the magnetic bead-based immunoassay: (a) fabricated chip and (b) 
measurement results for an on-chip PSA assay. 
Smart Polymer Lab Chip for Point-of-Care (POC) Diagnostics using Whole Blood [12, 13, 14] 
A disposable plastic biochip incorporating smart passive microfluidics with embedded on-chip 
pressure generator and integrated biosensor array has been developed for applications in clinical 
diagnostics and point-of-care testing [12, 13]. The fully integrated disposable biochip is capable of 
precise volume control with smart microfluidic manipulation without costly on-chip microfluidic 
components.  The schematic diagram of the biochip and fabricated chip are shown in Figure 3 (a) and (b). 
(a)                              (b)                                     (c)                                           (d) 
Figure 3.  Smart polymer lab-on-a-chip for blood analysis: (a) Schematic diagram; (b) Fabricated chip; (c) 
Hand-held reader; and (d) Measured glucose from whole blood. 
The biochip has a unique power source using on-chip pressure generators, for microfluidic 
manipulation, avoiding the need for complex microfluidic pumps. In addition, the disposable plastic 
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biochip has successfully been tested for the measurements of partial oxygen concentration, glucose, and 
lactate level in human blood using an integrated biosensor array. A handheld analyzer capable of 
multiparameter detection of clinically relevant parameters has also been developed to detect the signals 
from the cartridge type disposable biochip.  The testing result for electrochemical detection using the 
biochip and analyzer is shown in Figure 3 (d).   
In other configurations, a polymer lab-on-a-chip for monitoring of organophosphates and heavy metals 
(with emphasis on lead) with functional and rugged hand-held analyzer was developed for point-of-care 
detection of chronic neurotoxin/heavy metal exposure [14]. The organophosphates were detected by an 
enzyme activity assay to monitor activity of Acetylcholinesterase (ACHe) and Butyrylcholinesterase 
(BCHe).  The biomarkers of exposure for heavy metals were detected by monitoring Metallothionein 
(MT) concentrations using an indirect immunoassay.  The LOC was also used to test for Heat Shock 
Proteins (HSP27) using a sandwich immunoassay method.  These examples illustrate the versatility of 
this test platform for multiple detection methods for different clinical needs.  The lab-on-a-chips were 
used with a handheld analyzer for a user-friendly, reliable and rapid response POCT system.  Figure 4(a) 
shows the developed lab-on-a-chip with single “channel” assay system, where the capture antibody is pre-
conjugated in the detection chamber.  Figure 4(b) shows a hand-held point-of-care system developed for
the smart lab-on-a-chip which allows a chemiluminescence based sandwich immunoassay for the high 
sensitivity detection of protein or toxin biomarkers.  The lab-on-a-chip based analysis only requires ~ 20 
minutes as opposed to ~ 4-5 hours for a conventional ELISA assay. Figure 4(c) shows Ache activity 
inhibition results from whole blood samples clearly showing change in activity with neurotoxin exposure. 
These disposable lab-on-a-chips provide the high sensitivity and rapid analysis which is well suited for a 
point-of-care testing toward food safety, environmental monitor, biochemical hazardous material 
detection, or IVD.   
(a)                                                    (b)                                                         (c) 
Figure 4.  Smart lab-on-a-chip and analyzer for immunoassay: (a) Lab chip; (b) Hand-held analyzer; and 
(c) enzyme activity assay for Ache activity monitoring (to detect neurotoxin exposure). 
Novel Microfluidics-Based Microplate for Better Immunoassays with Femtogram/ml Level 
Sensitivity [15] 
A novel microplate (Optimiser™) has been recently developed at Siloam Biosciences that combines 
the typical SBS footprint of a 96-well microplate with a dedicated microfluidic channel connected to 
each well where binding events occur as shown in Figure 5 [15].  The conventional 96-well layout 
allows for the use of conventional peripheral microplate instrumentation such as automated pipetting 
stations and microplate readers; the microchannel dimensions (200 x 200 ȝm) promotes efficient 
binding reactions by a large increase in surface area to volume ratio of capture antibodies compared to 
standard ELISA techniques where capture antibodies are immobilized on the microplate well bottom.  
As shown in Figure 5, the Optimiser uses microfluidic channels as reaction chambers (instead of wells) 
allowing for the benefits of microfluidics with an ANSI/SBS compliant 96-well architecture. Figure 5 
(b) shows the operation sequence.  Reagents are sequentially added to the loading well, drawn into the 
channel by capillary forces and excess drawn out by absorbent pad.  The microfluidic design ensures 
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that the channel is not emptied by absorbent pad allowing static incubation step.  Subsequent liquid 
addition breaks capillary barrier at inlet and flow resumes. All assay reactions occur in the microfluidic 
channel at the bottom surface under each well.   
(a)                                                        (b)                                                            (c)  
Figure 5. Optimiser™ microplate illustration: (a) Optimiser™ microplate with magnified view of one 
cell; (b) Operation sequence of the Optimiser™ microplate; and (c) Pipetting into the Optimiser™. 
(a)                                                                                  (b) 
Figure 6. Analysis results: (a) Optimiser™ and Bio-Tek reader and (b) Human IL-4 sandwich 
immunoassay in Optimiser™ microplate. 
The surface area to volume ratio of each microfluidic reaction chamber represents a 50-fold increase 
when compared to the well of a conventional 96-well immunoassay plate. The improvement in the 
surface area to volume ratio increases binding kinetics dramatically and allow rapid reactions (5 to 10 
minutes incubation/step for 30 to 90 minutes immunoassays). The Optimiser provides significant reagent 
savings, time savings and elimination of traditional wash requirements. Owing to the rapid reaction 
kinetics at microfluidic scale, it is possible for us to repeat the sample load process multiple times (20, 
100 or even 250 times, each with 5 μl volume load followed by 5 min incubation step) using an 
automated liquid handling system and achieve extraordinary sensitivity for common assays, as shown in 
Figure 6  [15].  To the best of our knowledge this is the highest sensitivity ever reported for this assay.  
Optimiser can revolutionize biotech research by allowing researchers to reach sensitivity levels never 
possible to-date.  Furthermore, ~ 90%+ ELISA users still use the 96-well plate and Optimiser can serve as 
the ideal vehicle to deliver the power of microfluidics to a global user-base.   
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Conclusion 
Microfluidic samples in the microchannels have an extremely large surface area to volume ratio which 
increases binding kinetics dramatically and allow rapid reactions.  For example, the surface area to 
volume ratio of each microfluidic reaction chamber represents a 50-fold increase when compared to the 
well of a conventional 96-well immunoassay plate. This distinctive nature of microfluidic sample through 
the microchannel provides rapid and high sensitive immunoassays, allowing significant reagent and time 
savings.  Hence, femtogram/ml sensitivity of immunoassays can be successfully achieved using a novel 
microfluidics-based microplate.  This can revolutionize biotech research by allowing researchers to reach 
sensitivity levels never possible to-date.   With this high sensitivity, the combination of lab-on-a-chips 
and microfluidics is very suitable for the point-of-care testing (POCT) diagnostics with needs for a rapid 
TAT, high sensitivity and low assay cost.  In conclusion, the distinctive natures of microfluidics and lab-
on-a-chips, as a new game changer, opens a new realm of immunoassays and ELISA for clinical 
diagnostics IVD including POCT applications.  
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